KMT2A and acute myeloid leukemia: In this study of MLL/AF9-AML, we showed that somatic mutations remarkably accumulated during shortening leukemic onset and that driver mutations in the mouse sequencing reproduced human mutational profiles, including RAS pathway mutations.